Symbicort® Turbohaler®

DRUG3 trials

Sponsors

AstraZeneca, Teva Branded Pharmaceutical Products R&D, Inc., Zambon SpA

Conditions

AsthmaAsthma BronchialAsthma ChronicAsthmatic

Phase 2

Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

CompletedNCT02227394

Zambon SpAAsthma, Asthma Bronchial, Asthma Chronic +1

Start: 2014-08-31End: 2014-11-30Updated: 2022-01-27

Phase 3

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy

CompletedNCT00319306

AstraZenecaAsthma

Start: 2005-09-30End: 2006-12-31Target: 550Updated: 2009-03-17

Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®

CompletedNCT01803555

Teva Branded Pharmaceutical Products R&D, Inc.Asthma

Start: 2013-07-04End: 2014-03-20Updated: 2023-12-08

Related Papers

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma.

2016-03-1713 citations